Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Desvenlafaxine succinate sustained release (DVS SR) versus placebo in peri- and postmenopausal women with depression has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine succinate sustained-release (DVS SR) (desvenlafaxine succinate)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depression, Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-05-07